{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:51:36Z","timestamp":1649202696570},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00108-016-0083-1","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T08:50:05Z","timestamp":1465548605000},"page":"656-665","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperurik\u00e4mie und Gicht"],"prefix":"10.1007","volume":"57","author":[{"given":"M.","family":"Witt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schulze-Koops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"83_CR1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis 67:960\u2013966","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 73:1470\u20131476","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","volume":"73","author":"F Sivera","year":"2014","unstructured":"Sivera F, Andres M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, Durme C van, Echteld I van, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewe RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Muller-Ladner U, Ostergaard M, Zochling J, Falzon L, Heijde DM van der (2014) Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 73:328\u2013335","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/rheumatology\/kem058","volume":"46","author":"RG Thiele","year":"2007","unstructured":"Thiele RG, Schlesinger N (2007) Diagnosis of gout by ultrasound. Rheumatology 46:1116\u20131121","journal-title":"Rheumatology"},{"key":"83_CR5","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar3223","volume":"13","author":"C Pineda","year":"2011","unstructured":"Pineda C, Amezcua-Guerra LM, Solano C, Rodriguez-Henriquez P, Hernandez-Diaz C, Vargas A, Hofmann F, Gutierrez M (2011) Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 13:R4","journal-title":"Arthritis Res Ther"},{"key":"83_CR6","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-203487","volume":"73","author":"E Naredo","year":"2014","unstructured":"Naredo E, Uson J, Jimenez-Palop M, Martinez A, Vicente E, Brito E, Rodriguez A, Cornejo FJ, Castaneda S, Martinez MJ, Sanz J, Moller I, Batlle-Gualda E, Garrido J, Pascual E (2014) Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout? Ann Rheum Dis 73:1522\u20131528","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR7","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.22803","volume":"56","author":"TR Johnson","year":"2007","unstructured":"Johnson TR, Weckbach S, Kellner H, Reiser MF, Becker CR (2007) Clinical image: Dual-energy computed tomographic molecular imaging of gout. Arthritis Rheum 56:2809","journal-title":"Arthritis Rheum."},{"key":"83_CR8","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2014-205431","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Taylor WJ, Weatherall M, Fransen J, Jansen TL, Neogi T, Schumacher HR, Dalbeth N (2015) Imaging modalities for the classification of gout: systematic literature review and meta-analysis. Ann Rheum Dis 74:1868\u20131874","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.rdc.2014.01.004","volume":"40","author":"FM McQueen","year":"2014","unstructured":"McQueen FM, Doyle A, Dalbeth N (2014) Imaging in the crystal arthropathies. Rheum Dis Clin North Am 40:231\u2013249","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"83_CR10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Liote F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74:1789\u20131798","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of R (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431\u20131446","journal-title":"Arthritis Care Res"},{"key":"83_CR12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of R (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447\u20131461","journal-title":"Arthritis Care Res"},{"key":"83_CR13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW (2010) High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62:1060\u20131068","journal-title":"Arthritis Rheum."},{"key":"83_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7\u201313","journal-title":"Ann. Intern. Med."},{"key":"83_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/rheumatology\/kes223","volume":"52","author":"CF Kuo","year":"2013","unstructured":"Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology 52:127\u2013134","journal-title":"Rheumatology"},{"key":"83_CR16","first-page":"2429","volume":"31","author":"GC Borstad","year":"2004","unstructured":"Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA (2004) Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J\u00a0Rheumatol 31:2429\u20132432","journal-title":"J. Rheumatol."},{"key":"83_CR17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","volume":"64","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, Dalbeth N (2012) Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 64:2529\u20132536","journal-title":"Arthritis Rheum."},{"key":"83_CR18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr., Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450\u20132461","journal-title":"N. Engl. J. Med."},{"key":"83_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","volume":"12","author":"G Schett","year":"2016","unstructured":"Schett G, Dayer JM, Manger B (2016) Interleukin-1 function and role in rheumatic disease. Nat Rev Rheumatol 12:14\u201324","journal-title":"Nat Rev Rheumatol"},{"key":"83_CR20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2165\/11592290-000000000-00000","volume":"71","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger N (2011) Difficult-to-treat gouty arthritis: a disease warranting better management. Drugs 71:1413\u20131439","journal-title":"Drugs"},{"key":"83_CR21","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9:R28","journal-title":"Arthritis Res Ther"},{"key":"83_CR22","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","volume":"71","author":"N Schlesinger","year":"2012","unstructured":"Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK (2012) Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 71:1839\u20131848","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR23","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","volume":"70","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger N, Mysler E, Lin HY, De Meulemeester M, Rovensky J, Arulmani U, Balfour A, Krammer G, Sallstig P, So A (2011) Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheum Dis 70:1264\u20131271","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10157-011-0532-z","volume":"16","author":"N Anzai","year":"2012","unstructured":"Anzai N, Jutabha P, Amonpatumrat-Takahashi S, Sakurai H (2012) Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin Exp Nephrol 16:89\u201395","journal-title":"Clin. Exp. Nephrol."},{"key":"83_CR25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/BOR.0000000000000146","volume":"27","author":"C Diaz-Torne","year":"2015","unstructured":"Diaz-Torne C, Perez-Herrero N, Perez-Ruiz F (2015) New medications in development for the treatment of hyperuricemia of gout. Curr Opin Rheumatol 27:164\u2013169","journal-title":"Curr Opin Rheumatol"},{"key":"83_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207919","author":"F Perez-Ruiz","year":"2016","unstructured":"Perez-Ruiz F, Sundy JS, Miner JN, Cravets M, Storgard C, Group RS (2016) Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol. Ann Rheum Dis. doi:10.1136\/annrheumdis-2015-207919","journal-title":"Ann. Rheum. Dis."},{"key":"83_CR27","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","volume":"111","author":"JT Kratzer","year":"2014","unstructured":"Kratzer JT, Lanaspa MA, Murphy MN, Cicerchi C, Graves CL, Tipton PA, Ortlund EA, Johnson RJ, Gaucher EA (2014) Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci USA 111:3763\u20133768","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"83_CR28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1617","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW 2nd, Hamburger SA, Becker MA (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306:711\u2013720","journal-title":"JAMA"},{"key":"83_CR29","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar4318","volume":"15","author":"HS Baraf","year":"2013","unstructured":"Baraf HS, Becker MA, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, Rehrig CD, Ottery FD, Sundy JS, Yood RA (2013) Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy. Arthritis Res Ther 15:R137","journal-title":"Arthritis Res Ther"},{"key":"83_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/art.39684","author":"J Poiley","year":"2016","unstructured":"Poiley J, Steinberg AS, Choi YJ, Davis CS, Martin RL, McWherter CA, Boudes PF (2016) A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout. Arthritis Rheumatol. doi:10.1002\/art.39684 [Epub ahead of print]","journal-title":"Arthritis Rheumatol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0083-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0083-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0083-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:05:23Z","timestamp":1498320323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0083-1"}},"subtitle":["Neues zu einer alten Krankheit"],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0083-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]}}}